Are the Antilipidemic Drugs Prescribed to Reduce the Chance to Have Myocardial Infarction Increasing the Possibility to Have Myocardial Infarction Nowadays?
Author(s):
Huang Wei Ling
Antilipidemic drugs are used to reduce cholesterol with the main reason, to reduce the chance to have myocardial infarction. In this article, I will
demonstrate that these drugs used by the patients can increase the chance to have myocardial infarction even without arterial obstruction. This new
mechanism of development myocardial infarction is not studied by normal medical faculties because it is related to alterations in the energy level,
studied by Traditional Chinese Medicine, which exists for more than 5000 years. In this study, I will show two cases reports, the first was a 64 years-old,
female, which cholesterol levels was 256 mg/dl. It was prescribed atorvastatin but the patient did not used the medication because she asked for another
doctor which studies traditional Chinese medicine, and this doctor orientated her to do not use the medication because of this patient was presenting
no energy into the five internal massive organs such as Liver, Heart, Spleen, Lungs and Kidney, which corresponds to alteration characterizing this New
Global Immunodeficiency. The second case report was a 75 years-old male patient with no complaints. He had cholesterol of 129 mg/dl and his doctor
prescribed simvastatin but he did not use this medication because he asked another doctor with traditional Chinese medicine’s reasoning, which asked
him to do not use this kind of medication to prevent myocardial infarction. These organs are important for many different functions inside the body and
one of them are to produce the energy to allow the normal flow of Blood inside the blood vessels through the normal production of Yin, Yang (by the
energy of the Kidney), Qi (by the energy of Lungs and Liver) and Blood (by the energy of the Spleen). All these flow of energy inside the human’s body
is coordinated by the energy of the Heart. According to Ardnt-Scultz Law, created in 1888 by two German’s researchers, they say that any kind of high
concentrated medications can reduce even more our internal energy and can lead to death of this patient. Conclusion: The conclusion of study is that the use of medication to reduce cholesterol nowadays can induce myocardial infarction in this new type
of population that we are treating nowadays, considered immunodeficient, and can lead to death of this patient, even without evidence of myocardial
artery obstruction.
